These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 17948891

  • 1. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice.
    Yoo JH, Nam YS, Lee SY, Jang CG.
    Synapse; 2008 Jan; 62(1):8-13. PubMed ID: 17948891
    [Abstract] [Full Text] [Related]

  • 2. GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
    Yoo JH, Lee HK, Kim HC, Lee SY, Jang CG.
    Synapse; 2010 Apr; 64(4):274-9. PubMed ID: 19953653
    [Abstract] [Full Text] [Related]

  • 3. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
    Yoo JH, Cho JH, Yu HS, Lee KW, Lee BH, Jeong SM, Nah SY, Kim HC, Lee SY, Jang CG.
    J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD, Bartee JA, Leite-Browning ML, Blackshear MA.
    Cell Mol Biol (Noisy-le-grand); 2007 May 15; 53(4):15-22. PubMed ID: 17531156
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T, Kuroiwa M, Hamamura M, Yabuuchi K, Shimazoe T, Watanabe S, Nishi A, Yamamoto T.
    Neuropharmacology; 2006 Jun 15; 50(8):991-7. PubMed ID: 16563442
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
    Ke JJ, Chen HI, Jen CJ, Kuo YM, Cherng CG, Tsai YP, Ho MC, Tsai CW, Yu L.
    Toxicol Appl Pharmacol; 2008 Mar 01; 227(2):239-47. PubMed ID: 18076959
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.
    Auclair A, Drouin C, Cotecchia S, Glowinski J, Tassin JP.
    Eur J Neurosci; 2004 Dec 01; 20(11):3073-84. PubMed ID: 15579162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.